サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1622100

重要臓器サポートシステムおよびメディカルバイオニクスの世界市場規模：製品別、エンドユーザー別、地域別、範囲および予測

Global Vital Organs Support Systems And Medical Bionics Market Size By Product (Vital Organs Support Systems, Medical Bionics), By End-User (Hospitals, Ambulatory Surgical Centers), By Geographic Scope And Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
重要臓器サポートシステムおよびメディカルバイオニクスの世界市場規模：製品別、エンドユーザー別、地域別、範囲および予測
出版日: 2024年11月08日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

重要臓器サポートシステムおよびメディカルバイオニクスの市場規模と予測

重要臓器サポートシステムおよびメディカルバイオニクスの市場規模は、2024年に464億3,000万米ドルと評価され、2024年から2031年にかけてCAGR 9.60%で成長し、2031年には966億6,000万米ドルに達すると予測されています。この背景には、臓器提供者の不足、臓器移植症例の増加、遺伝性障害や事故による臓器移植が必要な人の増加、慢性疾患の発生率の増加があります。この調査レポートは、世界の重要臓器サポートシステムおよびメディカルバイオニクス市場を総合的に評価・分析しています。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界の重要臓器サポートシステムおよびメディカルバイオニクス市場の定義

臓器サポートシステムを構成する人工臓器は、人間の自然な臓器機能を模倣して作成され、欠損または損傷した臓器の代替や、すでに機能している臓器のサポートに使用されます。これらの人工臓器は生体組織に接続され、欠損した人間の臓器の代わりとなります。

生体や特定の生体部分を複製する機械システムの研究は、メディカルバイオニクスとして知られています。重要臓器サポートシステムおよびメディカルバイオニクスには、ヒトドナーへの依存を減らし、臓器拒絶反応のリスクを軽減し、さまざまな疾患に対してより安価な治療選択肢を提供するという利点があります。これらの利点は、メディカルバイオニクスや必須臓器をサポートするシステムの市場拡大に役立つと予想されます。

臓器支援システムおよびメディカルバイオニクスの世界市場概要

近年、重要臓器サポートシステムおよびメディカルバイオニクスの世界市場は大幅な拡大を経験しており、今後もシェアと金額の両面で大幅な拡大が見込まれます。この背景には、臓器提供者の不足、臓器移植症例の増加、遺伝性障害や事故による障害で臓器移植を必要とする人の増加、慢性疾患の発生率の増加があります。さらに、予測期間を通じて、高齢者人口の継続的な増加や製品技術の進歩などの要因が、メディカルバイオニクスおよび重要臓器サポートシステムの世界市場の成長を押し上げると予想されます。

しかし、メディカルバイオニクスおよび臓器サポートシステムの市場成長は、人工機器やメディカルバイオニクスの高コストや厳しい規制承認手続きによって制約を受けると予想されます。さらに、今後数年間は、有利な償還政策、官民からの財政支援、有利な医療保険制度が、メディカルバイオニクスと重要臓器サポートシステムの市場成長を支えると思われます。

目次

第1章 重要臓器サポートシステムおよびメディカルバイオニクスの世界市場：イントロダクション

  • 市場の定義
  • 市場セグメンテーション
  • 調査スケジュール
  • 前提条件
  • 制限事項

第2章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • データの三角測量
  • ボトムアップアプローチ
  • トップダウンアプローチ
  • 調査の流れ
  • 業界専門家による主要な洞察
  • データソース

第3章 エグゼクティブサマリー

  • 市場概要
  • エコロジーのマッピング
  • 絶対的収益機会
  • 市場の魅力
  • 重要臓器サポートシステムおよびメディカルバイオニクスの世界市場：地域別分析
  • 重要臓器サポートシステムおよびメディカルバイオニクスの世界市場：製品別
  • 重要臓器サポートシステムおよびメディカルバイオニクスの世界市場：エンドユーザー別
  • 今後の市場機会
  • 世界市場分割
  • 製品ライフライン

第4章 重要臓器サポートシステムおよびメディカルバイオニクスの世界市場展望

  • 世界の重要臓器サポートシステムおよびメディカルバイオニクスの進化
  • 促進要因
  • 抑制要因
  • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析
  • 価格分析
  • マクロ経済分析

第5章 重要臓器サポートシステムおよびメディカルバイオニクスの世界市場：製品別

  • 概要
  • バイタルオルガンサポートシステム
    • 人工心臓
    • 人工腎臓
    • 人工肝臓
    • その他
  • メディカル・バイオニクス
    • 心臓バイオニクス
    • 整形外科バイオニクス
    • 神経バイオニクス
    • その他

第6章 重要臓器サポートシステムおよびメディカルバイオニクスの世界市場：エンドユーザー別

  • 概要
  • 病院
  • 外来手術センター
  • その他

第7章 重要臓器サポートシステムおよびメディカルバイオニクスの世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東・アフリカ
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第8章 重要臓器サポートシステムおよびメディカルバイオニクスの世界市場：競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な発展
  • 企業の地域別フットプリント
  • 企業の業界フットプリント
  • ACEマトリックス

第9章 企業プロファイル

  • Abiomed Inc
  • Abbott Laboratories（St. Jude Medical）
  • Asahi Kasei Corporation（Evaheart Medical U.S.A. Inc）
  • Baxter International Inc
  • Boston Scientific Corporation
  • Cochlear Ltd
  • Edwards Lifesciences Corporation
  • Jarvik Heart Inc
  • Medtronic Plc（Covidien Ltd）
  • Ossur Americas Inc
  • Second Sight Medical Products Inc
  • SynCardia Systems LLC

第10章 VERIFIED MARKET INTELLIGENCE

  • VERIFIED MARKET INTELLIGENCEについて
  • ダイナミックなデータの可視化
目次
Product Code: 15317

Vital Organs Support Systems And Medical Bionics Market Size And Forecast

Vital Organs Support Systems And Medical Bionics Market size was valued at USD 46.43 Billion in 2024 and is projected to reach USD 96.66 Billion By 2031, growing at a CAGR of 9.60% from 2024 to 2031. This is brought on by a dearth of organ donors, an increase in organ transplant cases, a rise in the number of persons needing organ transplants due to hereditary or accidental disabilities, and a rise in the incidence of chronic diseases. The Global Vital Organs Support Systems And Medical Bionics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Vital Organs Support Systems And Medical Bionics Market Definition

The artificial organs that make up the Organ Support System are created to mimic natural human organ function and are used to replace missing or damaged organs as well as support already functioning organs. These synthetic organs connect to living tissues and take the place of missing human organs.

The study of mechanical systems that duplicate organisms or specific living organism parts is known as medical bionics. Artificial organ support systems and medical bionics have the advantages of lessening the dependence on human donors, reducing the risk of organ rejection, and providing a more affordable treatment option for a variety of disorders. These advantages are anticipated to assist the market for medical bionics and systems to support essential organs as they expand.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Vital Organs Support Systems And Medical Bionics Market Overview

In recent years, the global market for medical bionics and systems to support important organs has experienced significant expansion, and in the years to come, it is anticipated to continue to expand significantly both in terms of share and value. This is brought on by a dearth of organ donors, an increase in organ transplant cases, a rise in the number of persons needing organ transplants due to hereditary or accidental disabilities, and a rise in the incidence of chronic diseases. Additionally, throughout the forecast period, factors such as the continually growing elderly population, and advancements in product technologies are anticipated to boost the growth of the global market for medical bionics and vital organ support systems.

However, the market growth for medical bionics and vital organ support systems is anticipated to be constrained by the high cost of artificial devices and medical bionics as well as strict regulatory approval procedures. Moreover, in the coming years, favorable reimbursement policies, financial support from the public and private sectors, as well as favorable healthcare coverage schemes, will support the growth of the market for medical bionics and systems that support vital organs.

Global Vital Organs Support Systems And Medical Bionics Market Segmentation Analysis

The Global Vital Organs Support Systems And Medical Bionics Market is Segmented based on Product, End-User, And Geography.

Vital Organs Support Systems And Medical Bionics Market, By Product

  • Vital Organs Support Systems
  • Artificial Heart
  • Artificial Kidney
  • Artificial Liver
  • Others
  • Medical Bionics
  • Cardiac Bionics
  • Orthopedic Bionics
  • Neural Bionics
  • Others

Based on product, the market is segmented into vital organs support systems, and medical bionics. The vital organs support systems segment is segmented into artificial hearts, artificial livers, artificial kidneys, and others. The medical bionics market is classified into cardiac bionics, orthopedic bionics, neural bionics, and others. The vital organs support systems segment dominated the major market share of the vital organs support systems and medical bionics market. The growth of the segment is primarily attributed to a surge in patient acceptance that is poised to increase as more people become aware of medical bionics. Continuous advances in the fields of biomedical engineering and medical science are anticipated to increase the use rate of synthetic organs during the projected period.

Vital Organs Support Systems And Medical Bionics Market, By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Based on End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. the hospital segment dominated the major market share of the vital organs support systems and medical bionics market. The availability of numerous support departments, including MRI suites and ICUs, is responsible for the segment's expansion. Additionally, hospitals have more staff on hand to deal with complications. When complications arise during an operation, patients are frequently transferred from an ambulatory surgery center to the closest hospital, which will speed up the growth of the hospital segment throughout the forecast period.

Vital Organs Support Systems And Medical Bionics Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin Ameria
  • Middle East & Africa

Based on Geography, the Global Vital Organs Support Systems And Medical Bionics Market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market for medical bionics and systems to support key organs is dominated mostly by North America. This can be attributed to the rising prevalence of artificial organs in emerging markets, the existence of numerous key players participating in this market, the presence of a large number of players working in this industry, as well as the potential growth of healthcare spending. Furthermore, because cadaveric organ donation is so uncommon, artificial organ transplants are probably going to become more typical. An increasing number of new product approvals linked to the best use of innovative transplants are predicted to fuel market expansion over the forecast period. The industry is positioned to be driven by significant private-sector expenditures.

  • However, due to the rising prevalence of amputations from trauma and accidents, as well as brain injuries that cause visual and hearing loss, Asia-Pacific is predicted to have the fastest growth during the forecast period. Additionally, it is anticipated that demand for medical bionics and critical organ support systems will increase as a result of improved patient awareness and increased investment by major market players in developing economies, which is expected to fuel market growth throughout the forecast period for the market for these products.

Key Players

  • The "Global Vital Organs Support Systems And Medical Bionics Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Abiomed Inc., Abbott Laboratories (St. Jude Medical), Baxter International Inc., Second Sight Medical Products Inc, Boston Scientific Corporation, Cochlear Ltd, Edwards Lifesciences Corporation, Jarvik Heart Inc, Asahi Kasei Corporation (Evaheart Medical U.S.A. Inc), Medtronic Plc (Covidien Ltd), Ossur Americas Inc, SynCardia Systems LLC, and others.
  • Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.'

Key Developments

  • In 2020, Sonova Group unveiled its EXCITE-Pro platform, which was demonstrated by HANSATON, a manufacturer and provider of hearing systems.
  • Kindred Healthcare, LLC and Ekso Bionics Holdings, Inc. collaborated to pilot EksoNR, a robotic exoskeleton, in their long-term acute care hospitals in 2020.
  • In 2020, the Cobalt & Crome portfolio of Cardiac Resynchronization Therapy-Defibrillators (CRT-D) and Implantable Cardioverter-Defibrillators (ICD) from Medtronic Plc. received the Conformite Europeenne (CE) mark.
  • Ace Matrix Analysis
  • The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories
  • Active, Cutting Edge, Emerging, and Innovators.
  • Market Attractiveness
  • The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Vital Organs Support Systems And Medical Bionics market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
  • Porter's Five Forces
  • The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the global Vital Organs Support Systems And Medical Bionics market, gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Vital Organs Support Systems And Medical Bionics Market Geographical Analysis (CAGR %)
  • 3.6 Global Vital Organs Support Systems And Medical Bionics Market, By Product (USD Million)
  • 3.7 Global Vital Organs Support Systems And Medical Bionics Market, By End-User (USD Million)
  • 3.8 Future Market Opportunities
  • 3.9 Global Market Split
  • 3.10 Product Life Line

4 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET OUTLOOK

  • 4.1 Global Vital Organs Support Systems And Medical Bionics Evolution
  • 4.2 Drivers
    • 4.2.1 Driver 1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint 1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity 1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Vital Organs Support Systems
    • 5.2.1 Artificial Heart
    • 5.2.2 Artificial Kidney
    • 5.2.3 Artificial Liver
    • 5.2.4 Others
  • 5.3 Medical Bionics
    • 5.3.1 Cardiac Bionics
    • 5.3.2 Orthopedic Bionics
    • 5.3.3 Neural Bionics
    • 5.3.4 Others

6 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END-USER

  • 6.1 Overview
  • 6.2 Hospitals
  • 6.3 Ambulatory Surgical Centers
  • 6.4 Others

7 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Argentina
    • 7.5.3 Rest of Latin America
  • 7.6 Middle-East and Africa
    • 7.6.1 UAE
    • 7.6.2 Saudi Arabia
    • 7.6.3 South Africa
    • 7.6.4 Rest of Middle-East and Africa

8 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Developments
  • 8.4 Company Regional Footprint
  • 8.5 Company Industry Footprint
  • 8.6 ACE Matrix

9 COMPANY PROFILES

  • 9.1 Abiomed Inc
    • 9.1.1 Company Overview
    • 9.1.2 Company Insights
    • 9.1.3 Product Benchmarking
    • 9.1.4 Key Development
    • 9.1.5 Winning Imperatives
    • 9.1.6 Current Focus & Strategies
    • 9.1.7 Threat from Competition
    • 9.1.8 SWOT Analysis
  • 9.2 Abbott Laboratories (St. Jude Medical)
    • 9.2.1 Company Overview
    • 9.2.2 Company Insights
    • 9.2.3 Product Benchmarking
    • 9.2.4 Key Development
    • 9.2.5 Winning Imperatives
    • 9.2.6 Current Focus & Strategies
    • 9.2.7 Threat from Competition
    • 9.2.8 SWOT Analysis
  • 9.3 Asahi Kasei Corporation (Evaheart Medical U.S.A. Inc)
    • 9.3.1 Company Overview
    • 9.3.2 Company Insights
    • 9.3.3 Product Benchmarking
    • 9.3.4 Key Development
    • 9.3.5 Winning Imperatives
    • 9.3.6 Current Focus & Strategies
    • 9.3.7 Threat from Competition
    • 9.3.8 SWOT Analysis
  • 9.4 Baxter International Inc
    • 9.4.1 Company Overview
    • 9.4.2 Company Insights
    • 9.4.3 Product Benchmarking
    • 9.4.4 Key Development
    • 9.4.5 Winning Imperatives
    • 9.4.6 Current Focus & Strategies
    • 9.4.7 Threat from Competition
    • 9.4.8 SWOT Analysis
  • 9.5 Boston Scientific Corporation
    • 9.5.1 Company Overview
    • 9.5.2 Company Insights
    • 9.5.3 Product Benchmarking
    • 9.5.4 Key Development
    • 9.5.5 Winning Imperatives
    • 9.5.6 Current Focus & Strategies
    • 9.5.7 Threat from Competition
    • 9.5.8 SWOT Analysis
  • 9.6 Cochlear Ltd
    • 9.6.1 Company Overview
    • 9.6.2 Company Insights
    • 9.6.3 Product Benchmarking
    • 9.6.4 Key Development
    • 9.6.5 Winning Imperatives
    • 9.6.6 Current Focus & Strategies
    • 9.6.7 Threat from Competition
    • 9.6.8 SWOT Analysis
  • 9.7 Edwards Lifesciences Corporation
    • 9.7.1 Company Overview
    • 9.7.2 Company Insights
    • 9.7.3 Product Benchmarking
    • 9.7.4 Key Development
    • 9.7.5 Winning Imperatives
    • 9.7.6 Current Focus & Strategies
    • 9.7.7 Threat from Competition
    • 9.7.8 SWOT Analysis
  • 9.8 Jarvik Heart Inc
    • 9.8.1 Company Overview
    • 9.8.2 Company Insights
    • 9.8.3 Product Benchmarking
    • 9.8.4 Key Development
    • 9.8.5 Winning Imperatives
    • 9.8.6 Current Focus & Strategies
    • 9.8.7 Threat from Competition
    • 9.8.8 SWOT Analysis
  • 9.9 Medtronic Plc (Covidien Ltd)
    • 9.9.1 Company Overview
    • 9.9.2 Company Insights
    • 9.9.3 Product Benchmarking
    • 9.9.4 Key Development
    • 9.9.5 Winning Imperatives
    • 9.9.6 Current Focus & Strategies
    • 9.9.7 Threat from Competition
    • 9.9.8 SWOT Analysis
  • 9.10 Ossur Americas Inc
    • 9.10.1 Company Overview
    • 9.10.2 Company Insights
    • 9.10.3 Product Benchmarking
    • 9.10.4 Key Development
    • 9.10.5 Winning Imperatives
    • 9.10.6 Current Focus & Strategies
    • 9.10.7 Threat from Competition
    • 9.10.8 SWOT Analysis
  • 9.11 Second Sight Medical Products Inc
    • 9.11.1 Company Overview
    • 9.11.2 Company Insights
    • 9.11.3 Product Benchmarking
    • 9.11.4 Key Development
    • 9.11.5 Winning Imperatives
    • 9.11.6 Current Focus & Strategies
    • 9.11.7 Threat from Competition
    • 9.11.8 SWOT Analysis
  • 9.12 SynCardia Systems LLC
    • 9.12.1 Company Overview
    • 9.12.2 Company Insights
    • 9.12.3 Product Benchmarking
    • 9.12.4 Key Development
    • 9.12.5 Winning Imperatives
    • 9.12.6 Current Focus & Strategies
    • 9.12.7 Threat from Competition
    • 9.12.8 SWOT Analysis

10 VERIFIED MARKET INTELLIGENCE

  • 10.1 About Verified Market Intelligence
  • 10.2 Dynamic Data Visualization